CRANEWARE PLC

Regulatory Filings • Aug 1, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3910W

Craneware plc

01 August 2018

Craneware plc

("Craneware" or the "Company")

Appointment of Joint Broker

1 August 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce the appointment of Investec Bank plc as the Company's Joint Broker with immediate effect.

Peel Hunt remains the Company's Nominated Adviser and Joint Broker.

For further information, please contact:

Craneware plc	+44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Peel Hunt (NOMAD and Joint Broker)	+44 (0)20 7418 8900
Dan Webster/ George Sellar
Investec Bank (Joint Broker)	+44 (0) 20 7597 5970
Patrick Robb/ Sebastian Lawrence/ Henry Reast
Alma (Financial PR)	+44 (0)208 004 4217
Caroline Forde/ Robyn Fisher/ Josh Royston

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 300 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

APPRBMRTMBAJBAP